UCB BIOPHARMA SRL

FC037714
Active Anderlecht
1,281 employees website.com
Life sciences and medical technology
U

UCB BIOPHARMA SRL

FC037714
Founded 1 Oct 2020 Active Anderlecht, Belgium 1,281 employees website.com
Life sciences and medical technology

Previous Company Names

UCB BIOPHARMA UK 12 Nov 2020 — 10 Nov 2022
Accounts Submitted 20 Aug 2025
Confirmation
Net assets £255M £605M 2023 year on year
Total assets £4,457M £241M 2023 year on year
Total Liabilities £4,203M £364M 2023 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

60 Allee De La Recherche Anderlecht 1070 Belgium

Website

www.example.com

Full company profile for UCB BIOPHARMA SRL (FC037714), an active life sciences and medical technology company based in Anderlecht, Belgium. Incorporated 1 Oct 2020. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2023
Type full
Next accounts 31 Dec 2025
Due by

Balance Sheet & P&L (2020–2023)

Cash in Bank

£75.66M

Decreased by £1.74M (-2%)

Net Assets

£254.73M

Decreased by £604.50M (-70%)

Total Liabilities

£4202.54M

Increased by £363.93M (+9%)

Turnover

£2272.21M

Decreased by £252.31M (-10%)

Employees

1281

Increased by 17 (+1%)

Debt Ratio

94%

Increased by 12 (+15%)

Financial History

Revenue, profit, EBITDA and key financial figures

2023
31 Dec Year End
2022
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

2 active 1 resigned
Status
Jean-luc Pascal FleurialDirectorFrenchBelgium6112 Nov 2020Active
Sandrine DufourDirectorFrenchBelgium591 Oct 2020Active

Shareholders

Shareholders (1)

Ucb Biopharma
NaN%

Persons with Significant Control

Persons with Significant Control (0)

No PSC information available

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
20 Aug 2025AccountsAnnual accounts made up to 31 Dec 2024
21 Feb 2025OfficersAppointment of Stevan Graham Shaw as director
20 Feb 2025OfficersTermination Person Authorised Overseas Company
14 Aug 2024AccountsAnnual accounts made up to 31 Dec 2023
26 Jul 2024OfficersTermination of Dhavalkumar Dhirajlal Patel as director on 1 Jul 2024
20 Aug 2025 Accounts

Annual accounts made up to 31 Dec 2024

21 Feb 2025 Officers

Appointment of Stevan Graham Shaw as director

20 Feb 2025 Officers

Termination Person Authorised Overseas Company

14 Aug 2024 Accounts

Annual accounts made up to 31 Dec 2023

26 Jul 2024 Officers

Termination of Dhavalkumar Dhirajlal Patel as director on 1 Jul 2024

Recent Activity

Latest Activity

Annual accounts made up to 31 Dec 2024

10 months ago on 20 Aug 2025

Appointment of Stevan Graham Shaw as director

1 years ago on 21 Feb 2025

Termination Person Authorised Overseas Company

1 years ago on 20 Feb 2025

Annual accounts made up to 31 Dec 2023

1 years ago on 14 Aug 2024

Termination of Dhavalkumar Dhirajlal Patel as director on 1 Jul 2024

1 years ago on 26 Jul 2024